1. Aviv A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med. 2002 Nov;80(11):689–695. [PubMed] 2. Epel E, Blackburn E, Lin J, et al. Accelerated telomere shortening in response to exposure to life stress. PNAS. 2004;101:17312–17315. [PubMed] 3. Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005 Feb 7;579(4):859–862. [PubMed] 4. Chan SW, Blackburn EH. Telomerase and ATM/Tel1p protect telomeres from nonhomologous end joining. Mol Cell. 2003 May;11(5):1379–1387. [PubMed] 5. Blackburn EH. Structure and function of telomeres. Nature. 1991 Apr 18;350(6319):569–573. [PubMed] 6. Edo MD, Andres V. Aging, telomeres, and atherosclerosis. Cardiovasc Res. 2005 May 1;66(2):213–221. [PubMed] 7. Blackburn EH. Telomere states and cell fates. Nature. 2000 Nov 2;408(6808):53–56. [PubMed] 8. Erusalimsky JD, Kurz DJ. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol. 2005 Aug-Sep;40(8-9):634–642. [PubMed] 9. Benetos A, Gardner JP, Zureik M, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 2004 Feb;43(2):182–185. [PubMed] 10. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):842–846. [PubMed] 11. Kurz DJ, Kloeckener-Gruissem B, Akhmedov A, et al. Degenerative Aortic Valve Stenosis, but not Coronary Disease, Is Associated With Shorter Telomere Length in the Elderly. Arterioscler Thromb Vasc Biol. 2006 Apr 20; [PubMed] 12. von Zglinicki T, Serra V, Lorenz M, et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest. 2000 Nov;80(11):1739–1747. [PubMed] 13. Zhai G, Aviv A, Hunter DJ, et al. Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study. Ann Rheum Dis. 2006 Nov;65(11):1444–1448. [PMC free article] [PubMed] 14. Valdes AM, Richards JB, Gardner JP, et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int. 2007 Mar 9; [PubMed] 15. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 2006 Feb;29(2):283–289. [PubMed] 16. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005 Aug 20-26;366(9486):662–664. [PubMed] 17. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005 May 3;111(17):2171–2177. [PubMed] 18. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol. 2006 Aug;60(2):174–180. [PubMed] 19. Honig LS, Schupf N, Lee JH, Tang MX, Mayeux R. Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol. 2006 Aug;60(2):181–187. [PubMed] 20. Cawthon R, Smith K, O’Brien E, Sivatchenko A, Kerber R. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395. [PubMed] 21. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312–17315. [PubMed] 22. Simon NM, Smoller JW, McNamara KL, et al. Telomere Shortening and Mood Disorders: Preliminary Support for a Chronic Stress Model of Accelerated Aging. Biol Psychiatry. 2006 Mar 31;60:432–435. [PubMed] 23. Cherkas LF, Aviv A, Valdes AM, et al. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell. 2006 Oct;5(5):361–365. [PubMed]
24. Epel ES. Telomeres: A new ‘psychobiomarker’ for a lifespan approach? Current Directions in Psychology. 2008 in press.
25. Folkman S, Lazarus RS. Coping as a mediator of emotion. J Pers Soc Psychol. 1988 Mar;54(3):466–475. [PubMed]
26. Lazarus R, Folkman S. Stress, appraisal, and coping. Springer-Verlag; New York: 1984.
27. Folkman S, Lazarus R. If it changes it must be a process: Study of emotion nad coping during three stages of a college examination. Journal of Personality and Social Psychology. 1985;48:150–170. [PubMed] 28. McCrae R. Situational determinants of coping responses: Loss, threat, and challenge. Journal of Personality and Social Psychology. 1984;46(4):919–928. [PubMed] 29. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior. 1983;24:385–396. [PubMed] 30. Mendes WB, Major B, McCoy S, Blascovich J. How attributional ambiguity shapes physiological and emotional responses to social rejection and acceptance. J Pers Soc Psychol. 2008 Feb;94(2):278–291. [PMC free article] [PubMed]
31. Folkman S, Moskowitz J. The scope of social psychology: Theory and applications. Psychology Press; Hove, UK: 2007. Positive affect and meaning-focused coping during significant psychological stress; pp. 193–208.
32. Folkman S. The case for positive emotions in the stress process. Anxiety Stress Coping. 2008 Jan;21(1):3–14. [PubMed]
33. Park CL, Folkman S. Meaning in the context of stress and coping. Review of General Psychology. 1997;2:115–144.
34. Tennen H, Affleck G. Benefit-finding and benefit-reminding. In: Snyder CR, Lopez SJ, editors. Handbook of positive psycholog. 584-597. Oxford University Press; London: 2002.
35. Folkman S, Moskowitz J, Ozer E, Park C. Positive meaningful events and coping in the context of HIV/AIDS. In: Gottlieb B, editor. Coping with Chronic Stress. Plenum; New York: 1997. pp. 293–314.
36. Lazarus RS, Kanner AD, Folkman S. Emotions: A cognitive-phenomenological analysis. In: Plutchik R, Kellerman H, editors. Theories of emotion. Academic Press; New York: 1980.
37. Bower J, Low C, Moskowitz J, Sepah S, Epel E. Pathways from benefit finding to physical health: Enhanced psychological and physiological responses to stress. Social and Personality Psychology Compass. 2008 in press.
38. Epel E, McEwen B, Ickovics J. Embodying psychological thriving: Physical thriving in response to stress. Journal of Social Issues. 1998;54:301–322.
39. Kirschbaum C, Pirke K, Hellhammer D. The “Trier Social Stress Test”--A tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28:76–81. [PubMed] 40. Blascovich J, Mendes WB, Tomaka J, Salomon K, Seery M. The robust nature of the biopsychosocial model challenge and threat: a reply to Wright and Kirby. Pers Soc Psychol Rev. 2003;7(3):234–243. [PubMed] 41. Lundberg U, Frankenhaeuser M. Pituitary-adrenal and sympathetic-adrenal correlates of distress and effort. Journal of Psychosomatic Research. 1980;24:125–130. [PubMed] 42. Chandola T, Britton A, Brunner E, et al. Work stress and coronary heart disease: what are the mechanisms? Eur Heart J. 2008 Mar;29(5):640–648. [PubMed] 43. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001 Oct 23;104(17):2024–2028. [PubMed] 44. Sloan RP, Huang MH, Sidney S, Liu K, Williams OD, Seeman T. Socioeconomic status and health: is parasympathetic nervous system activity an intervening mechanism? Int J Epidemiol. 2005 Apr;34(2):309–315. [PMC free article] [PubMed] 45. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998 Jan 15;338(3):171–179. [PubMed] 46. Adam E, Gunnar M. Relationship functioning and home and work demands predict individual differences in diurnal cortisol patterns in women. Psychoneuroendocrinology. 2001;26:189–208. [PubMed] 47. Matthews K, Schwartz J, Cohen S, Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med. 2006 Sep-Oct;68(5):657–661. [PubMed] 48. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute. 2000;92:994–1000. [PubMed]
49. Epel E, Burke H, Wolkowitz O. Psychoneuroendocrinology of Aging: Focus on anabolic and catabolic hormones. In: Aldwin C, Spiro A, Park C, editors. Handbook of Health Psychology of Aging. Guildford Press; 2007. pp. 119–141.
50. Dallman MF, Akana SF, Strack AM, Hanson ES, Sebastian RJ. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann N Y Acad Sci. 1995 Dec 29;771:730–742. [PubMed] 51. Hermans EJ, Putman P, Baas JM, Gecks NM, Kenemans JL, van Honk J. Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1052–1061. [PubMed] 52. Liu J, Mori A. Stress, aging, and brain oxidative damage. Neurochem Res. 1999 Nov;24(11):1479–1497. [PubMed]
53. Sterling P, Eyer J. Allostasis: A new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook of Life Stress: Cognition and Health. John Wiley & Sons, Ltd.; 1988. pp. 629–649.
54. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007 Jul;87(3):873–904. [PubMed]
55. Epel ES. Psychological stress and metabolic stress: A recipe for accelerated cellular aging? Hormones (Athens) 2008 in press.
56. Mason J. Organization of psychoendocrine mechanisms. Psychosomatic Medicine. 1968;39:565–591. [PubMed] 57. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull. 2004 May;130(3):355–391. [PubMed] 58. Bernhardt PC, Dabbs JM, Fielden JA, Lutter CD. Testosterone changes during vicarious experiences of winning and losing among fans at sporting events. Physiology and Behavior. 1998;65:59–62. [PubMed] 59. Chichinadze K, Chichinadze N. Stress-induced increase of testosterone: Contributions of social status and sympathetic reactivity. Physiol Behav. 2008 Apr 8;8:8. [PubMed]
60. Mendes WB, Ayduk O, Epel ES, Akinola M, Gyurak A. When stress is good for you: Neuroendocrine concomitants of physiological thriving. Harvard University; Boston: 2008.
61. Gramzow RH, Willard G, Mendes WB. Big tales and cool heads: academic exaggeration is related to cardiac vagal reactivity. Emotion. 2008 Feb;8(1):138–144. [PubMed]
62. Whitmore R, Maninger N, Wolfson W, Mendes WB, Epel ES. Relaxation increases DHEA; Paper presented at: Society of Behavioral Medicine; San Diego. 2008.
63. Akinola M, Mendes WB. The dark side of creativity: biological vulnerability and negative mood leads to greater artistic creativity. Personality and Social Psychology. 2008 under review.
64. Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J Abnorm Psychol. 2000 Aug;109(3):504–511. [PubMed] 65. Brosschot JF, Thayer JF. Heart rate response is longer after negative emotions than after positive emotions. Int J Psychophysiol. 2003 Nov;50(3):181–187. [PubMed] 66. Gerin W, Davidson KW, Christenfeld NJ, Goyal T, Schwartz JE. The role of angry rumination and distraction in blood pressure recovery from emotional arousal. Psychosom Med. 2006 Jan-Feb;68(1):64–72. [PubMed] 67. Glynn LM, Christenfeld N, Gerin W. The role of rumination in recovery from reactivity: cardiovascular consequences of emotional states. Psychosom Med. 2002 Sep-Oct;64(5):714–726. [PubMed] 68. McCullough ME, Orsulak P, Brandon A, Akers L. Rumination, fear, and cortisol: an in vivo study of interpersonal transgressions. Health Psychol. 2007 Jan;26(1):126–132. [PubMed] 69. Epel E, Lin J, Wilhelm F, et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006;31:277–287. [PubMed] 70. Kiaris H, Schally AV. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):226–231. [PubMed] 71. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004 Mar 5;94(4):514–524. [PubMed] 72. Wetterau LA, Francis MJ, Ma L, Cohen P. Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells. J Clin Endocrinol Metab. 2003 Jul;88(7):3354–3359. [PubMed] 73. Akiyama M, Hideshima T, Hayashi T, et al. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res. 2002 Jul 1;62:3876–3882. [PubMed] 74. Kimura A, Ohmichi M, Kawagoe J, et al. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene. 2004 Jun 3;23(26):4505–4515. [PubMed] 75. Sato R, Maesawa C, Fujisawa K, et al. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut. 2004 Jul;53(7):1001–1009. [PMC free article] [PubMed] 76. Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends in Cognitive Science. 2008;12(4):163–169. [PMC free article] [PubMed]
77. Rosch E. More than mindfulness: When you have a tiger by the tail, let it eat you. Taylor & Francis; United Kingdom: 2007.
78. Rosch E. More Than Mindfulness: When You Have a Tiger by the Tail, Let It Eat You. Psychological Inquiry. 2007 in press.
79. Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of Mindfulness. Journal of Clinical Psychology. 2006 Mar;62(3):373–386. [PubMed]
80. Bishop SR, Lau M, Shapiro S, et al. Mindfulness: A proposed operational definition. Clinical Psychology: Science and Practice. 2004 Fal11(3):230–241.
81. Brown K, Ryan R, Creswell JD. Mindfulness: Theoretical foundations and evidence for its salutary effects. Psychological Inquiry. 2007;18(4):211–237.
82. Kabat-Zinn J. Wherever you go, there you are: Mindfulness meditation in everyday life. Hyperion; New York: 1994.
83. Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol. 2006 Mar;62(3):373–386. [PubMed] 84. Teasdale JD, Moore RG, Hayhurst H, Pope M, Williams S, Segal ZV. Metacognitive awareness and prevention of relapse in depression: empirical evidence. J Consult Clin Psychol. 2002 Apr;70(2):275–287. [PubMed] 85. Brown KW, Ryan RM. The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology. 2003 Apr;84(4):822–848. [PubMed] 86. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using Self-Report Assessment Methods to Explore Facets of Mindfulness. Assessment. 2006 Mar;13(1):27–45. [PubMed]
87. Kabat-Zinn J. Full Catastrophe Living. Dell Publishing; New York: 1990.
88. Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies subsystems of attention. Cogn Affect Behav Neurosci. 2007 Jun;7(2):109–119. [PubMed] 89. Chan D, Woollacott M. Effects of level of meditation experience on attentional focus: is the efficiency of executive or orientation networks improved? J Altern Complement Med. 2007 Jul-Aug;13(6):651–657. [PubMed] 90. Wenk-Sormaz H. Meditation can reduce habitual responding. Altern Ther Health Med. 2005 Mar-Apr;11(2):42–58. [PubMed]
91. Siegel D. The Mindful Brain. W.W. Norton and Company; New York: 2007.
92. Slagter HA, Lutz A, Greischar LL, et al. Mental training affects distribution of limited brain resources. PLoS Biol. 2007 Jun;5(6):e138. [PMC free article] [PubMed] 93. Nielsen L, Kaszniak AW. Awareness of Subtle Emotional Feelings: A Comparison of Long-Term Meditators and Nonmeditators. Emotion. 2006 Aug;6(3):392–405. [PubMed] 94. Farb NAS, Segal ZV, Mayberg H, et al. Attending to the present: Mindfulness meditation reveals distinct neural modes of self-reference. Social Cognitive and Affective Neuroscience. 2007 Dec;2(4):313–322. [PMC free article] [PubMed] 95. Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport: For Rapid Communication of Neuroscience Research. 2005 Nov;16(17):1893–1897. [PMC free article] [PubMed]
96. Heppner WL, Kernis MH. “Quiet ego” functioning: The complementary roles of mindfulness, authenticity, and secure high self-esteem. Taylor & Francis; United Kingdom: 2007.
97. Barnes S, Brown KW, Krusemark E, Campbell WK, Rogge RD. The role of mindfulness in romantic relationship satisfaction and responses to relationship stress. Journal of Marital & Family Therapy. 2007 Oct;33(4):482–500. [PubMed]
98. Klatt MD, Buckworth J, Malarkey WB. Effects of low-dose Mindfulness-Based Stress Reduction (MBSR-ld) on working adults. Health Education and Behavior. 2008 May 9; Epub ahead of print.
99. Wallace BA, Shapiro SL. Mental Balance and Well Being: Building bridges between Buddhism and Western Psychology. Am. Psychologist. 2006;61:690–701. [PubMed] 100. Astin JA. Stress reduction through mindfulness meditation. Effects on psychological symptomatology, sense of control, and spiritual experiences. Psychother Psychosom. 1997;66(2):97–106. [PubMed] 101. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits: A meta-analysis. Journal of Psychosomatic Research. 2004 Jul;57(1):35–43. [PubMed]
102. Bormann J, Carrico A. Increases in Positive Reappraisal Coping During a Mantram Repetition Intervention Mediate Sustained Reductions in Anger in HIV-Positive Persons. 2007 under review.
103. Robins JL, McCain NL, Gray DP, Elswick RK, Jr., Walter JM, McDade E. Research on psychoneuroimmunology: tai chi as a stress management approach for individuals with HIV disease. Appl Nurs Res. 2006 Feb;19(1):2–9. [PMC free article] [PubMed] 104. Gaab J, Blattler N, Menzi T, Pabst B, Stoyer S, Ehlert U. Randomized controlled evaluation of the effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects. Psychoneuroendocrinology. 2003 Aug;28(6):767–779. [PubMed] 105. Gaab J, Sonderegger L, Scherrer S, Ehlert U. Psychoneuroendocrine effects of cognitive-behavioral stress management in a naturalistic setting--a randomized controlled trial. Psychoneuroendocrinology. 2006 May;31(4):428–438. [PubMed] 106. Teasdale J, Segal Z, Williams J. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help? Behavior Research and Therapy. 1995;33:25–39. [PubMed] 107. Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822–848. [PubMed] 108. Verplanken B, Friborg O, Wang CE, Trafimow D, Woolf K. Mental habits: metacognitive reflection on negative self-thinking. J Pers Soc Psychol. 2007 Mar;92(3):526–541. [PubMed] 109. Jain S, Shapiro SL, Swanick S, et al. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med. 2007 Feb;33(1):11–21. [PubMed] 110. Ma SH, Teasdale JD. Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Journal of Consulting and Clinical Psychology. 2004 Feb;72(1):31–40. [PubMed] 111. Arch JJ, Craske MG. Mechanisms of mindfulness: Emotion regulation following a focused breathing induction. Behaviour Research and Therapy. 2006 Dec;44(12):1849–1858. [PubMed] 112. Creswell JD, Way BM, Eisenberger NI, Lieberman MD. Neural correlates of dispositional mindfulness during affect labeling. Psychosomatic Medicine. 2007 Jul-Aug;69(6):560–565. [PubMed] 113. Lieberman MD, Eisenberger NI, Crockett MJ, Tom SM, Pfeifer JH, Way BM. Putting feelings into words: Affect labeling disrupts amygdala activity in response to affective stimuli. Psychological Science. 2007 May;18(5):421–428. [PubMed] 114. Davidson RJ, Jackson DC, Kalin NH. Emotion, plasticity, context, and regulation: Perspectives from affective neuroscience. Psychological Bulletin Special Issue: Psychology in the 21st Century. 2000 Nov;126(6):890–909. [PubMed] 115. Shapiro SL, Schwartz GE, Bonner G. Effects of mindfulness-based stress reduction on medical and premedical students. J Behav Med. 1998 Dec;21(6):581–599. [PubMed] 116. Schneider RH, Alexander CN, Staggers F, et al. A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year. Am J Hypertens. 2005 Jan;18(1):88–98. [PMC free article] [PubMed] 117. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006 Jun 12;166(11):1218–1224. [PubMed] 118. Maclean C, Walton K, Wenneberg S, et al. Effects of the Transcendental Meditation program on adaptive mechanisms: Changes in hormone levels and respones to stress after 4 months of practice. Psychoneuroendocrinology. 1997;22:277–295. [PubMed] 119. Infante JR, Peran F, Martinez M, et al. ACTH and beta-endorphin in transcendental meditation. Physiol Behav. 1998 Jun 1;64(3):311–315. [PubMed] 120. Walton K, Pugh N, Gelderloos P, Macrae P. Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. Journal of Alternative and Complementary Medicine. 1995;1:263–283. [PubMed] 121. Dienstbier R. Arousal and physiological toughness: Implications for mental and physical health. Psychological Review. 1989;96:84–100. [PubMed] 122. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol. 1971 Sep;221(3):795–799. [PubMed] 123. Dusek JA, Chang BH, Zaki J, et al. Association between oxygen consumption and nitric oxide production during the relaxation response. Med Sci Monit. 2006 Jan;12(1):CR1–10. [PubMed] 124. Benson H, Steinert RF, Greenwood MM, Klemchuk HM, Peterson NH. Continuous measurement of O2 consumption and CO2 elimination during a wakeful hypometabolic state. J Human Stress. 1975 Mar;1(1):37–44. [PubMed] 125. Kesterson J, Clinch NF. Metabolic rate, respiratory exchange ratio, and apneas during meditation. Am J Physiol. 1989 Mar;256(3 Pt 2):R632–638. [PubMed] 126. Cahn BR, Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull. 2006 Mar;132(2):180–211. [PubMed] 127. Ditto B, Eclache M, Goldman N. Short-term autonomic and cardiovascular effects of mindfulness body scan meditation. Ann Behav Med. 2006 Dec;32(3):227–234. [PubMed] 128. Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun. 2007 Nov;21(8):1038–1049. [PubMed] 129. Tang YY, Ma Y, Wang J, et al. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17152–17156. [PubMed] 130. Walsh R, Shapiro SL. The meeting of meditative disciplines and Western Psychology. Am. Psychologist. 2006;61:227–239. [PubMed] 131. Antoni MH, Cruess S, Cruess DG, et al. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Annals of Behavorial Medicine. 2000;22:29–37. [PubMed] 132. Antoni MH. Stress management effects on psychological, endocrinological, and immune functioning in men with HIV infection: empirical support for a psychoneuroimmunological model. Stress. 2003 Sep;6(3):173–188. [PubMed] 133. Hammerfald K, Eberle C, Grau M, et al. Persistent effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects--a randomized controlled trial. Psychoneuroendocrinology. 2006 Apr;31(3):333–339. [PubMed] 134. Lazar SW, Bush G, Gollub RL, Fricchione GL, Khalsa G, Benson H. Functional brain mapping of the relaxation response and meditation. Neuroreport: For Rapid Communication of Neuroscience Research. 2000 May;11(7):1581–1585. [PubMed]
135. Lazar SW. Neural correlates of respiratory control during mindfulness meditation: Behavioral influences on respiration; Paper presented at: American Psychosomatic Society; Baltimore. 2008.
136. Wolkowitz O, Epel E, Reus V. Stress hormone-related psychopathology: Pathophysiological and treatment implications. World Journal of Biological Psychiatry. 2001;2:113–141. [PubMed] 137. Glaser JL, Brind J, Vogelman JH, et al. Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the transcendental meditation (TM) and TM-Sidhi programs. Journal of Behavioral Medicine. 1992;15:327–341. [PubMed] 138. Arias AJ, Steinberg K, Banga A, Trestman RL. Systematic review of the efficacy of meditation techniques as treatments for medical illness. J Altern Complement Med. 2006 Oct;12(8):817–832. [PubMed] 139. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004 Jul;57(1):35–43. [PubMed] 140. Castillo-Richmond A, Schneider R, Alexander C, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke. 2000;31:568–573. [PubMed] 141. Walton KG, Schneider RH, Nidich S. Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality. Cardiol Rev. 2004 Sep-Oct;12(5):262–266. [PMC free article] [PubMed] 142. Kim DH, Moon YS, Kim HS, et al. Effect of Zen Meditation on serum nitric oxide activity and lipid peroxidation. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):327–331. [PubMed] 143. Schneider RH, Nidich SI, Salerno JW, et al. Lower lipid peroxide levels in practitioners of the Transcendental Meditation program. Psychosom Med. 1998 Jan-Feb;60(1):38–41. [PubMed] 144. Epel ES, Lin J, Wilhelm FH, et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006 Apr;31(3):277–287. [PubMed]